Literature DB >> 28069171

Steric exclusion chromatography for purification of cell culture-derived influenza A virus using regenerated cellulose membranes and polyethylene glycol.

Pavel Marichal-Gallardo1, Michael M Pieler2, Michael W Wolff3, Udo Reichl4.   

Abstract

Steric exclusion chromatography has been used for the purification of proteins and bacteriophages using monoliths. The operation is carried out by mixing a crude sample containing the target species with a predetermined concentration and molecular weight of polyethylene glycol (PEG) and loading it onto a non-reactive hydrophilic surface. Product capture occurs by the mutual steric exclusion of PEG between the product and the matrix. Selectivity is significantly influenced by target product size. Product elution is achieved by decreasing the PEG concentration. In this study, a 75cm2 cellulose membrane adsorber was used for the purification of a clarified and inactivated influenza A virus broth produced in a 5L bioreactor using suspension Madin Darby canine kidney cells. Product recovery was above 95% based on hemagglutination activity and single radial immunodiffusion assays. Maximum depletion of double stranded host cell DNA and total protein was 99.7% and 92.4%, respectively. Purified virus particles showed no aggregation with a monodisperse peak around 84nm. 250mL of the clarified inactivated virus broth was purified within 40min. The surface area productivity based on the recovery of the viral hemagglutinin antigen was 28-50mgm-2h-1 depending on the feed and loading conditions.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Influenza A virus purification; Membrane chromatography; Polyethylene glycol; Regenerated cellulose; Steric exclusion chromatography

Mesh:

Substances:

Year:  2016        PMID: 28069171     DOI: 10.1016/j.chroma.2016.12.076

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  9 in total

1.  The Suitability of Latex Particles to Evaluate Critical Process Parameters in Steric Exclusion Chromatography.

Authors:  Friederike Eilts; Marleen Steger; Keven Lothert; Michael W Wolff
Journal:  Membranes (Basel)       Date:  2022-04-30

2.  OP7, a novel influenza A virus defective interfering particle: production, purification, and animal experiments demonstrating antiviral potential.

Authors:  Marc D Hein; Heike Kollmus; Pavel Marichal-Gallardo; Sebastian Püttker; Dirk Benndorf; Yvonne Genzel; Klaus Schughart; Sascha Y Kupke; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2020-12-04       Impact factor: 4.813

3.  Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles.

Authors:  Marc D Hein; Prerna Arora; Pavel Marichal-Gallardo; Michael Winkler; Yvonne Genzel; Stefan Pöhlmann; Klaus Schughart; Sascha Y Kupke; Udo Reichl
Journal:  BMC Biol       Date:  2021-05-03       Impact factor: 7.431

Review 4.  Lentiviral Vector Bioprocessing.

Authors:  Christopher Perry; Andrea C M E Rayat
Journal:  Viruses       Date:  2021-02-09       Impact factor: 5.048

Review 5.  Development of virus-like particles-based vaccines against coronaviruses.

Authors:  Chean Yeah Yong; Winnie Pui Pui Liew; Hui Kian Ong; Chit Laa Poh
Journal:  Biotechnol Prog       Date:  2022-08-05

6.  Purification of influenza virus-like particles using sulfated cellulose membrane adsorbers.

Authors:  Sofia B Carvalho; A Raquel Fortuna; Michael W Wolff; Cristina Peixoto; Paula M Alves; Udo Reichl; Manuel Jt Carrondo
Journal:  J Chem Technol Biotechnol       Date:  2017-12-16       Impact factor: 3.174

7.  Performance of an acoustic settler versus a hollow fiber-based ATF technology for influenza virus production in perfusion.

Authors:  Gwendal Gränicher; Juliana Coronel; Felix Trampler; Ingo Jordan; Yvonne Genzel; Udo Reichl
Journal:  Appl Microbiol Biotechnol       Date:  2020-04-15       Impact factor: 4.813

Review 8.  Polysaccharide-based chromatographic adsorbents for virus purification and viral clearance.

Authors:  Guy-Alain Junter; Laurent Lebrun
Journal:  J Pharm Anal       Date:  2020-01-13

9.  Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine.

Authors:  Keven Lothert; Anna F Offersgaard; Anne F Pihl; Christian K Mathiesen; Tanja B Jensen; Garazi Peña Alzua; Ulrik Fahnøe; Jens Bukh; Judith M Gottwein; Michael W Wolff
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.